Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART [8]

AIDS

Volumn 21, Issue 18, 2007, Pages 2564-2565

  Lopriore, Enrico ^a   Rozendaal, Lieke ^a   Gelinck, Luc B S ^a   Bökenkamp, Regina ^a   Boelen, Carolien C A ^a   Walther, Frans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOMYOPATHY; CASE REPORT; COMPLETE HEART BLOCK; DIZYGOTIC TWINS; ECHOCARDIOGRAPHY; FEMALE; FERTILIZATION IN VITRO; HEART MASSAGE; HEART OUTPUT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LETTER; MOTHER; PREGNANCY; PRIORITY JOURNAL;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARDIOMYOPATHY, DILATED; DISEASE TRANSMISSION, VERTICAL; DISEASES IN TWINS; FEMALE; HEART BLOCK; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 36349032255     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f12060     Document Type: Letter

References (12)

1. Joint United Nations Program on HIV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: December 2006. Available at: http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf. Accessed: September 2007.
2. Capparelli E, Rakhmanina N, Mirochnick M. Pharmacotherapy of perinatal HIV. Semin Fetal Neonatal Med 2005; 10:161-175.
3. Blanche S, Tardieu M, Benhammou V, Warszawski J, Rustin P. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 2006; 20:1685-1690.
4. Godfried MH, Boer K, Beuger S, Scherpbier HJ, Kuijpers TW. A neonate with macrosomia, cardiomyopathy and hepatomegaly born to an HIV-infected mother. Eur J Pediatr 2005; 164:190-192.
5. Lavigne JE, Shearer WT, Thompson B, Orav EJ, Starc TJ, Colan SD, et al. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study. Cardiovasc Toxicol 2004; 4:187-197.
6. Zareba KM, Lavigne JE, Lipshultz SE. Cardiovascular effects of HAART in infants and children of HIV-infected mothers. Cardiovasc Toxicol 2004; 4:271-279.
7. Hornberger LK, Lipshultz SE, Easley KA, Colan SD, Schwartz M, Kaplan S, et al. Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study. Am Heart J 2000; 140:575-584.
8. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 2002; 360:368-373.
9. Noguera A, Fortuny C, Munoz-Almagro C, Sanchez E, Vilaseca MA, Artuch R, et al. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals. Pediatrics 2004; 114:e598-e603.
10. Poirier MC, Divi RL, Al Harthi L, Olivero OA, Nguyen V, Walker B, et al. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003; 33:175-183.
11. Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000; 25:261-268.
12. Brinkman K, Ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 1998; 12:1735-1744.